Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest grouped for convenient reading
    • Bonus reports for subscribers, and
    • Regular postings from your editor.
View a sample and get more information
August 11, 2017

Recent Stories

From Drug Benefit News - During its Aug. 8 second-quarter earnings call, CVS Health Corp. — the nation’s largest PBM covering nearly 90 million members — said it aims to return to healthy earnings growth by “partnering more broadly” with other PBMs and plans. Citing its ongoing work with payers to drive volume and capture market share, CVS Health highlighted its partnership with OptumRx launched in July to provide a “90-day retail solution” to OptumRx’s administrative-services only (ASO) clients. CVS also underscored its collaboration announced in June with Cigna Corp., aligning Cigna-administered health benefits with CVS pharmacies and MinuteClinics (DBN 7/14/17, p. 3). Read more

CVS Health Corp. and Express Scripts Holding Co. recently posted their 2018… Read more

When Merck announced on July 24 the entry of its biosimilar for… Read more

Highmark Health officials recently won an award from the Drug Enforcement Agency… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

August 2, 2017
CMS Unveils 2018 Standard Control Formulary

CMS will remove 17 drugs across 10 classes from its Standard Control Formulary in 2018, will launch Transform Value program in oncology, obesity, respiratory areas

July 31, 2017
Express Scripts Releases 2018 National Preferred Formulary

Express Scripts releases 2018 National Preferred Formulary, adding 64 drug exclusions for a total of 159. PBM says it expects employers who use the NPF will save an additional $2.5 billion next year

July 24, 2017
Second Biosimilar Remicade Launches

Samsung Bioepis’ Renflexis (infliximab-abda) is now available in the U.S. from Merck at a 35% discount to the wholesale acquisition cost of its reference drug, Remicade. Renflexis is second biosimilar Remicade after Inflectra (infliximab-dyyb)

It's quick and easy to sign up for FREE access to!

Why do I need to register?